Stanford Health Policy

Tainayah Thomas, PhD, Stanford Health Policy & Luis A. Rodriguez, PhD, Kaiser Permanente, organized a great opening evening for early-stage investigators conducting #diabetes & #healthequity research at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Center for Diabetes Translational Research meeting, with Julie Schmittdiel, PhD, and Alyce Adams, PhD.

Stanford University School of Medicine researchers Jonathan Chen and Mary K. Goldstein are using data science and machine learning to help doctors make better informed decisions and health-care facilities to adopt a precision stewardship approach to combatting antimicrobial resistance.

The discovery of antibiotics nearly a century ago revolutionized the treatment of infectious diseases around the world. But today,?700,000 people?die each year from infections that have become resistant to antibiotics—and microbial mortality is expected to jump dramatically to 10 million by 2050. So Stanford University School of Medicine researchers Jonathan Chen and Mary K. Goldstein are using data science and machine learning to help doctors make better informed decisions and health-care facilities to adopt a precision stewardship approach to combatting antimicrobial resistance.

The U.S. House passed a bill that would ban the use of a metric known as quality-adjusted life-years (QALYs) in coverage and payment determinations for federal health-care programs. SHP's Joshua Salomon writes in this Health Affairs commentary the bill would compromise the evaluation of medical treatments.

Natalia Serna, PhD, is this year’s Rosenkranz Prize for her research examining how price ceilings on oral contraceptives impact women’s health and their access to medicine in low- to middle-income countries, particularly those of Latin America. Serna, an assistant professor of health policy and?a faculty fellow at the?Stanford Institute for Economic Policy Research, explores large scale health systems and institutions in low- to middle-income countries with the goal of informing the design of health insurance markets and the provision of public programs in these countries.

This new study by SHP's Adrienne Sabety examines the association between prescriber workforce exit, long-term opioid treatment discontinuation, and clinical outcomes.

Paul Wise and Lauren Stoffel concede U.S. immigration policy has always experienced big ups and downs. What makes this moment unique, they write in this commentary, is that the contentious public sentiment is bearing down on an unprecedented number of unaccompanied children.

In his new advisory on the public health crisis of firearm violence, U.S. General Surgeon General Dr. Vivek Murthy cites research by Stanford Health Policy's Maya Rossin-Slater, which lays out the devastating long-term impacts of school shootings on the classmates who survive them.

More than?38 million?Americans had #diabetes in 2021—or 11.6% of the population—with the largest disease burden falling on Native, Black and Hispanic populations. The cost of diabetes care rose to?$412.9 billion?in 2022, accounting for one in four health-care dollars spent in this country. Some 60 researchers and leaders in the field recently gathered at Stanford University to brainstorm and network about how to translate diabetes research in the lab and take that research into the clinic. Learn More: https://lnkd.in/g8pH7UaT (Great graphics by Lane Change Consulting)

The federal government needs to do more to address the persistent racial and ethnic gaps plaguing the U.S. health-care system, declares a new report by the National Academies of Sciences, Engineering, and Medicine. SHP's Josh Salomon and Alyce Adams contributed to the report. "The report presents a sobering diagnosis of persistent inequities in the U.S. health-care system, at the same time it lays out specific, concrete recommendations for policies and actions that can drive progress toward eliminating these inequities," says Salomon, professor of health policy.